Cargando…
Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial
BACKGROUND: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic–hyperoxic training (IHHT) may be a suitable alternative. METHODS: This is a prospective, si...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241980/ https://www.ncbi.nlm.nih.gov/pubmed/30487981 http://dx.doi.org/10.1136/openhrt-2018-000891 |
_version_ | 1783371802684162048 |
---|---|
author | Tuter, Denis S Kopylov, Philippe Y Syrkin, Abram L Glazachev, Oleg S Komarov, Roman N Katkov, Andrei I Severova, Ljudmila P Ivanova, Ekaterina V Zhang, Young Saner, Hugo |
author_facet | Tuter, Denis S Kopylov, Philippe Y Syrkin, Abram L Glazachev, Oleg S Komarov, Roman N Katkov, Andrei I Severova, Ljudmila P Ivanova, Ekaterina V Zhang, Young Saner, Hugo |
author_sort | Tuter, Denis S |
collection | PubMed |
description | BACKGROUND: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic–hyperoxic training (IHHT) may be a suitable alternative. METHODS: This is a prospective, single-centre, randomised controlled trial. 127 patients with ischaemic heart disease and indication for coronary artery bypass graft (CABG) surgery from the Cardiology Clinic IM Sechenov First Moscow State Medical University were randomly assigned to IHHT, IHHT-control or RIP. Primary endpoint was serum concentration of troponin I and lactate 2 and 24 hours after surgery. RESULTS: Median value for troponin I 24 hours after surgery was 1.068 (0.388–1.397) ng/mL in the IHHT group and was significantly lower compared with IHHT-controls with 1.980 (1.068–3.239) ng/mL (p=0.012) and to the RIP group with 1.762 (1.288–2.186) ng/mL (p=0.029), while there was no significant difference between RIP and the IHHT-control. Serum lactate after surgery was 1.74 (1.23–2.04) mmol/L in the IHHT group and was also significantly lower compared with IHHT-controls with 2.10 (1.80–2.29) mmol/L (p=0.045) and RIP with 2.12 (1.91–2.33) mmol/L (p=0.032). No significant complications or serious adverse events were observed during IHHT. Intraoperative and early postoperative complications did not differ significantly between groups. CONCLUSIONS: The results of this first trial using IHHT for myocardial protection against perioperative ischaemic myocardial injury in patients undergoing CABG surgery are promising and further larger trials should be done with adequate power to detect clinical rather than surrogate marker benefits. |
format | Online Article Text |
id | pubmed-6241980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-62419802018-11-28 Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial Tuter, Denis S Kopylov, Philippe Y Syrkin, Abram L Glazachev, Oleg S Komarov, Roman N Katkov, Andrei I Severova, Ljudmila P Ivanova, Ekaterina V Zhang, Young Saner, Hugo Open Heart Basic and Translational Research BACKGROUND: Although remote ischaemic preconditioning (RIP) provides protection against myocardial ischaemia and reperfusion injury during cardiac surgery, it is not widely used. Systemic intermittent hypoxic–hyperoxic training (IHHT) may be a suitable alternative. METHODS: This is a prospective, single-centre, randomised controlled trial. 127 patients with ischaemic heart disease and indication for coronary artery bypass graft (CABG) surgery from the Cardiology Clinic IM Sechenov First Moscow State Medical University were randomly assigned to IHHT, IHHT-control or RIP. Primary endpoint was serum concentration of troponin I and lactate 2 and 24 hours after surgery. RESULTS: Median value for troponin I 24 hours after surgery was 1.068 (0.388–1.397) ng/mL in the IHHT group and was significantly lower compared with IHHT-controls with 1.980 (1.068–3.239) ng/mL (p=0.012) and to the RIP group with 1.762 (1.288–2.186) ng/mL (p=0.029), while there was no significant difference between RIP and the IHHT-control. Serum lactate after surgery was 1.74 (1.23–2.04) mmol/L in the IHHT group and was also significantly lower compared with IHHT-controls with 2.10 (1.80–2.29) mmol/L (p=0.045) and RIP with 2.12 (1.91–2.33) mmol/L (p=0.032). No significant complications or serious adverse events were observed during IHHT. Intraoperative and early postoperative complications did not differ significantly between groups. CONCLUSIONS: The results of this first trial using IHHT for myocardial protection against perioperative ischaemic myocardial injury in patients undergoing CABG surgery are promising and further larger trials should be done with adequate power to detect clinical rather than surrogate marker benefits. BMJ Publishing Group 2018-11-10 /pmc/articles/PMC6241980/ /pubmed/30487981 http://dx.doi.org/10.1136/openhrt-2018-000891 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Basic and Translational Research Tuter, Denis S Kopylov, Philippe Y Syrkin, Abram L Glazachev, Oleg S Komarov, Roman N Katkov, Andrei I Severova, Ljudmila P Ivanova, Ekaterina V Zhang, Young Saner, Hugo Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
title | Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
title_full | Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
title_fullStr | Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
title_full_unstemmed | Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
title_short | Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
title_sort | intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial |
topic | Basic and Translational Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241980/ https://www.ncbi.nlm.nih.gov/pubmed/30487981 http://dx.doi.org/10.1136/openhrt-2018-000891 |
work_keys_str_mv | AT tuterdeniss intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT kopylovphilippey intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT syrkinabraml intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT glazachevolegs intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT komarovromann intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT katkovandreii intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT severovaljudmilap intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT ivanovaekaterinav intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT zhangyoung intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial AT sanerhugo intermittentsystemichypoxichyperoxictrainingformyocardialprotectioninpatientsundergoingcoronaryarterybypasssurgeryfirstresultsfromasinglecentrerandomisedcontrolledtrial |